secwatch.observer — SEC 8-K summary
======================================

Issuer:     BriaCell Therapeutics Corp. (BCTX)
CIK:        0001610820
Form:       8-K
Filed at:   2024-09-12T23:59:59+00:00
Accession:  0001493152-24-036055
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BriaCell closes $8.5M public offering of 12.3M shares at $0.69 each
-------------------------------------------------------------------

- Gross proceeds of $8,504,250 from sale of 12,325,000 common shares at $0.69/share.
- Placement agent ThinkEquity received 7.5% cash fee and 5-year warrants for 616,250 shares at $0.8625.
- Net proceeds to be used for working capital, general corporate purposes, and advancing business objectives.
- Offering closed on September 12, 2024; securities sold under effective shelf registration statement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1610820/000149315224036055/0001493152-24-036055-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1610820/000149315224036055/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-036055

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer